$EXPO
EXPONENT INC

2023 Q4 Form 10-Q Financial Statement

#000095017023058876 Filed on November 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $122.9M $133.3M
YoY Change -3.5% 2.34%
Cost Of Revenue $9.028M $8.400M
YoY Change -38.86% -30.37%
Gross Profit $113.9M $125.0M
YoY Change 1.14% 5.74%
Gross Profit Margin 92.65% 93.75%
Selling, General & Admin $84.80M $82.10M
YoY Change 2.15% 24.42%
% of Gross Profit 74.47% 65.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.416M $2.300M
YoY Change 30.24% 26.93%
% of Gross Profit 2.12% 1.84%
Operating Expenses $95.48M $99.40M
YoY Change 5.44% 16.94%
Operating Profit $18.39M $33.93M
YoY Change -16.52% -25.05%
Interest Expense $1.929M $1.900M
YoY Change 52.85% 985.71%
% of Operating Profit 10.49% 5.6%
Other Income/Expense, Net $9.765M $84.00K
YoY Change 35.21% -100.85%
Pretax Income $30.09M $34.02M
YoY Change -1.41% -3.99%
Income Tax $9.159M $9.479M
% Of Pretax Income 30.44% 27.87%
Net Earnings $20.93M $24.54M
YoY Change -7.08% -4.73%
Net Earnings / Revenue 17.03% 18.4%
Basic Earnings Per Share $0.48
Diluted Earnings Per Share $0.41 $0.48
COMMON SHARES
Basic Shares Outstanding 50.62M 50.85M
Diluted Shares Outstanding 51.65M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $187.2M $137.1M
YoY Change 15.91% -17.22%
Cash & Equivalents $187.2M $137.1M
Short-Term Investments
Other Short-Term Assets $25.02M $24.50M
YoY Change 42.29% 61.81%
Inventory
Prepaid Expenses
Receivables $167.4M $181.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $379.5M $343.3M
YoY Change 8.7% 0.23%
LONG-TERM ASSETS
Property, Plant & Equipment $75.32M $76.25M
YoY Change 14.92% 19.28%
Goodwill $8.607M $8.607M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.727M $4.816M
YoY Change 85.79% 251.02%
Total Long-Term Assets $267.2M $259.1M
YoY Change 12.52% 15.6%
TOTAL ASSETS
Total Short-Term Assets $379.5M $343.3M
Total Long-Term Assets $267.2M $259.1M
Total Assets $646.8M $602.5M
YoY Change 10.25% 6.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.489M $19.60M
YoY Change -48.06% -26.5%
Accrued Expenses $17.64M $99.50M
YoY Change -13.86% 16.18%
Deferred Revenue $21.71M $10.49M
YoY Change 15.26% -31.11%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $161.9M $129.7M
YoY Change 1.81% 1.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.426M $4.136M
YoY Change 45.48% 61.94%
Total Long-Term Liabilities $3.426M $4.136M
YoY Change 45.48% 61.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $161.9M $129.7M
Total Long-Term Liabilities $3.426M $4.136M
Total Liabilities $290.7M $248.8M
YoY Change 9.32% 8.56%
SHAREHOLDERS EQUITY
Retained Earnings $574.1M $566.5M
YoY Change 8.56% 11.83%
Common Stock $321.5M $320.2M
YoY Change 6.79% 8.12%
Preferred Stock
YoY Change
Treasury Stock (at cost) $536.5M $529.3M
YoY Change 6.13% 14.66%
Treasury Stock Shares
Shareholders Equity $356.1M $353.6M
YoY Change
Total Liabilities & Shareholders Equity $646.8M $602.5M
YoY Change 10.25% 6.31%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $20.93M $24.54M
YoY Change -7.08% -4.73%
Depreciation, Depletion And Amortization $2.416M $2.300M
YoY Change 30.24% 26.93%
Cash From Operating Activities $71.35M $22.20M
YoY Change 75.87% -26.41%
INVESTING ACTIVITIES
Capital Expenditures $1.956M $3.300M
YoY Change -33.36% -199.76%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$1.956M -$3.300M
YoY Change -33.36% -0.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.01M -29.60M
YoY Change -21.29% -60.6%
NET CHANGE
Cash From Operating Activities 71.35M 22.20M
Cash From Investing Activities -1.956M -3.300M
Cash From Financing Activities -20.01M -29.60M
Net Change In Cash 49.39M -10.70M
YoY Change 304.35% -77.83%
FREE CASH FLOW
Cash From Operating Activities $71.35M $22.20M
Capital Expenditures $1.956M $3.300M
Free Cash Flow $69.40M $18.90M
YoY Change 84.39% -43.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-29
dei Entity Central Index Key
EntityCentralIndexKey
0000851520
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-29
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-18655
dei Entity Registrant Name
EntityRegistrantName
EXPONENT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0218904
dei Entity Address Address Line1
EntityAddressAddressLine1
149 COMMONWEALTH DRIVE
dei Entity Address City Or Town
EntityAddressCityOrTown
MENLO PARK
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
326-9400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
EXPO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50622438
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137099000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161458000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6400000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6193000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
181754000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170114000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24463000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17585000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
343316000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
349157000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
109435000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
103034000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76246000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65539000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24302000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18007000
CY2023Q3 us-gaap Goodwill
Goodwill
8607000
CY2022Q4 us-gaap Goodwill
Goodwill
8607000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
54448000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53909000
CY2023Q3 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
90727000
CY2022Q4 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
89437000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4816000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2006000
CY2023Q3 us-gaap Assets
Assets
602462000
CY2022Q4 us-gaap Assets
Assets
586662000
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
19640000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
29115000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
93828000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105822000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10489000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18834000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5700000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5258000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
129657000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
159029000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4136000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2355000
CY2023Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
93070000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
91183000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21964000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13343000
CY2023Q3 us-gaap Liabilities
Liabilities
248827000
CY2022Q4 us-gaap Liabilities
Liabilities
265910000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
66000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
66000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
320152000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
301002000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3775000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3587000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
566518000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
528810000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15040000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15064000
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
529326000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
505539000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
353635000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
320752000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
602462000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
586662000
CY2023Q3 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
124959000
CY2022Q3 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
115143000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
383317000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
351231000
CY2023Q3 expo Revenue From Reimbursement
RevenueFromReimbursement
8377000
CY2022Q3 expo Revenue From Reimbursement
RevenueFromReimbursement
12036000
expo Revenue From Reimbursement
RevenueFromReimbursement
30549000
expo Revenue From Reimbursement
RevenueFromReimbursement
34707000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133336000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127179000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413866000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
385938000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
74011000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
62779000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
241028000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
189982000
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
10997000
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8822000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
30863000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
25742000
CY2023Q3 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
8377000
CY2022Q3 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
12036000
expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
30549000
expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
34707000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6018000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6729000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18498000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16700000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
99403000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
90366000
us-gaap Operating Expenses
OperatingExpenses
320938000
us-gaap Operating Expenses
OperatingExpenses
267131000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
33933000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
36813000
us-gaap Operating Income Loss
OperatingIncomeLoss
92928000
us-gaap Operating Income Loss
OperatingIncomeLoss
118807000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1858000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
638000
us-gaap Investment Income Net
InvestmentIncomeNet
5221000
us-gaap Investment Income Net
InvestmentIncomeNet
834000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1774000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3975000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7659000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17926000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3337000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12880000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17092000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34017000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33476000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
105808000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
101715000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9479000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9034000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26398000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21909000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
24538000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
24442000
us-gaap Net Income Loss
NetIncomeLoss
79410000
us-gaap Net Income Loss
NetIncomeLoss
79806000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51203000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51492000
us-gaap Net Income Loss
NetIncomeLoss
55364000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
337494000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51197000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51934000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51645000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52008000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51680000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52489000
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.78
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.72
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
24538000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
24442000
us-gaap Net Income Loss
NetIncomeLoss
79410000
us-gaap Net Income Loss
NetIncomeLoss
79806000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-515000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1493000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-188000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3153000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24023000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22949000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79222000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
76653000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
320752000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1143000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6627000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
327000
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10497000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-9920000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
100000
us-gaap Dividends
Dividends
27319000
us-gaap Net Income Loss
NetIncomeLoss
54872000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
357079000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
569000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2308000
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
16970000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-515000
CY2023Q3 us-gaap Dividends
Dividends
13374000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
24538000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
353635000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1070000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5939000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
111843000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1660000
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10200000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-12904000
us-gaap Dividends
Dividends
25737000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137099000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148443000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24359000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-149244000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161458000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297687000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
557000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1999000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
30783000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1493000
CY2022Q3 us-gaap Dividends
Dividends
12416000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
24442000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
319800000
us-gaap Profit Loss
ProfitLoss
79410000
us-gaap Profit Loss
ProfitLoss
79806000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6535000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5224000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1911000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2112000
us-gaap Share Based Compensation
ShareBasedCompensation
17177000
us-gaap Share Based Compensation
ShareBasedCompensation
16072000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-539000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3955000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13551000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28265000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5886000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7583000
expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
451000
expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
132000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7094000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5140000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13124000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11211000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-8345000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3971000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56043000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53237000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14422000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9108000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14422000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9108000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9920000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12904000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16970000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
142195000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1812000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1627000
us-gaap Payments Of Dividends
PaymentsOfDividends
40894000
us-gaap Payments Of Dividends
PaymentsOfDividends
37084000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-65972000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-190556000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2817000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates. </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4045000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
13393000
CY2023Q3 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
2379000
CY2022Q3 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
6996000
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
10727000
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
18040000
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
159827000
CY2023Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
107223000
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
107223000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
152890000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
101354000
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
101354000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51203000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51492000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51197000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51934000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51645000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52008000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51680000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52489000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63333
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24835
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
105849000
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
100731000
CY2023Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
107223000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
101354000
CY2023Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-2769000
CY2022Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-4925000
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
5271000
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-20884000
us-gaap Income Taxes Paid
IncomeTaxesPaid
27753000
us-gaap Income Taxes Paid
IncomeTaxesPaid
24349000
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10497000
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10200000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13803000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8090000
expo Leasehold Improvements Obtained In Exchange For Right Of Use Asset
LeaseholdImprovementsObtainedInExchangeForRightOfUseAsset
3219000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
618000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
846000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6400000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6193000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
181754000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170114000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6193000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1911000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1704000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6400000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133336000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127179000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413866000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
385938000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
33933000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
36813000
us-gaap Operating Income Loss
OperatingIncomeLoss
92928000
us-gaap Operating Income Loss
OperatingIncomeLoss
118807000
CY2023Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1814000
CY2022Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2090000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
17242000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
9541000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2361000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1723000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6535000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5224000
CY2023Q3 expo Number Of Client Comprised More Than Ten Percent Of Revenue Or Accounts Receivable
NumberOfClientComprisedMoreThanTenPercentOfRevenueOrAccountsReceivable
0
expo Number Of Client Comprised More Than Ten Percent Of Revenue Or Accounts Receivable
NumberOfClientComprisedMoreThanTenPercentOfRevenueOrAccountsReceivable
0
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1715000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1518000
us-gaap Operating Lease Payments
OperatingLeasePayments
5516000
us-gaap Operating Lease Payments
OperatingLeasePayments
5083000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1699000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6669000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5763000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4945000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4336000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1860000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
8099000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33371000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5707000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
27664000
CY2023Q2 expo Concession Amount
ConcessionAmount
2000000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-058876-index-headers.html Edgar Link pending
0000950170-23-058876-index.html Edgar Link pending
0000950170-23-058876.txt Edgar Link pending
0000950170-23-058876-xbrl.zip Edgar Link pending
expo-20230929.htm Edgar Link pending
expo-20230929.xsd Edgar Link pending
expo-ex31_1.htm Edgar Link pending
expo-ex31_2.htm Edgar Link pending
expo-ex32_1.htm Edgar Link pending
expo-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
expo-20230929_def.xml Edgar Link unprocessable
expo-20230929_lab.xml Edgar Link unprocessable
expo-20230929_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
expo-20230929_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
expo-20230929_cal.xml Edgar Link unprocessable